Since potentiation of BMP9 signaling might be an effective way to cure PAH and HHT, it would also be a promising therapeutic approach that enhances the EC–MC interaction or conveys corresponding signaling to treat those diseases. The gene discussed is GDF2; the disease is pulmonary arterial hypertension.